
SPR Therapeutics
SPR Therapeutics LLC: Innovating neurostimulation pain therapies through advanced medical devices.

SPR Therapeutics LLC: Innovating neurostimulation pain therapies through advanced medical devices.
Founded with a mission to revolutionize pain management, SPR Therapeutics LLC focuses on developing advanced neurostimulation therapies. The company offers the SPRINT PNS System, a minimally invasive, non-opioid solution for chronic and acute pain. Their innovative products include a skin-mounted external stimulator, percutaneous lead, and small adhesive pads. SPR Therapeutics aims to provide effective pain relief options for both physicians and patients, targeting the healthcare market with cutting-edge medical devices.
Notable figures associated with SPR Therapeutics include key investors and medical professionals who support the company's vision. The company has achieved significant milestones, such as FDA clearance for their SPRINT PNS System and positive clinical outcomes that demonstrate the efficacy of their technology. SPR Therapeutics has made a substantial impact on the field of pain management by offering alternative solutions to opioid treatments, enhancing patient quality of life and advancing medical practices.
Companies similar to SPR Therapeutics include Spark Biomedical, Hypersound Medical, Nevro and Scion Neurostim.
SPR Therapeutics was founded in 2010.
SPR Therapeutics' headquarters is located in Cleveland, OH, US.
SPR Therapeutics' most recent funding round was for $25M (USD) in February 2024.
As of Feb 1, 2024, SPR Therapeutics has disclosed funding of $188.8M (USD). Undisclosed round amounts are excluded.
SPR Therapeutics has 229 employees as of Feb 5, 2024.
Scion Neurostim
scionneurostim.com